M

McKesson Europe AG
XHAM:CLS1

Watchlist Manager
McKesson Europe AG
XHAM:CLS1
Watchlist
Price: 24.4 EUR Market Closed
Market Cap: 5B EUR
Have any thoughts about
McKesson Europe AG?
Write Note

McKesson Europe AG
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

McKesson Europe AG
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
M
McKesson Europe AG
XHAM:CLS1
Free Cash Flow
-€27.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medios AG
XETRA:ILM1
Free Cash Flow
€123.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

McKesson Europe AG
Glance View

Market Cap
5B EUR
Industry
Health Care

McKesson Europe AG traces its roots back over a century, intertwining its growth story with the evolving landscape of healthcare in Europe. As a pivotal player in the distribution and retail of pharmaceuticals, McKesson Europe bridges the critical gap between manufacturers and patients. They operate a vast network of pharmacies spread across numerous countries, alongside an extensive distribution system. This infrastructure ensures medicines and health products swiftly reach their destinations, whether it be sprawling urban areas or remote rural locales. Through this network, McKesson Europe not only guarantees the delivery of essential drugs but also emphasizes efficiency and reliability, crafting a reputation that enhances its commercial success. Revenue streams for McKesson Europe derive from its multifaceted approach to healthcare services. The company thrives on both the wholesaling aspect, where it supplies drugs and health products to independent pharmacies and hospitals, and its retail operations through pharmacy chains. Moreover, McKesson Europe extends its business model by providing management services to independent pharmacies, optimizing their operations and supply chains. With the ever-growing demand for healthcare solutions in Europe, the company capitalizes on this pressing need, utilizing its vast logistical capabilities and deep industry knowledge to maintain its position as a leader in the pharmaceutical distribution and retail sectors. This strategic combination of services enables McKesson Europe AG to sustain its business momentum, adapting to the changing needs of the healthcare market.

CLS1 Intrinsic Value
Not Available
M

See Also

What is McKesson Europe AG's Free Cash Flow?
Free Cash Flow
-27.5m EUR

Based on the financial report for Mar 31, 2022, McKesson Europe AG's Free Cash Flow amounts to -27.5m EUR.

Back to Top